Delivery Order SPE2DB20D3103-SPE2DB25FP6X2
- Not listed
- The Defense Logistics Agency awarded a $12.5K firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on July 25, 2025, with an ultimate completion date of July 28, 2025. This non-set-aside, competitively awarded contract represents a routine pharmaceutical procurement fulfilling federal medical supply needs. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the Defense...
- The Defense Logistics Agency awarded a delivery order valued at $15,404.48 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-competitive delivery order utilizes firm fixed pricing and is sourced from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support federal healthcare operations....
- The Defense Logistics Agency awarded a delivery order valued at $10,844.61 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 21, 2025, with an ultimate completion date of July 22, 2025. This firm fixed-price delivery order, which is not set-aside, represents a single pharmaceutical procurement under the company's broader contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $6,099.74 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packages) on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a child award under the company's larger pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $5,457.38 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on July 22, 2025, with an ultimate completion date of July 23, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which is also the location of AmerisourceBergen's corporate headquarters. The delivery order represents a single...
- The Defense Logistics Agency awarded a delivery order valued at $12,690.78 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a delivery order valued at $6,732.17 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) on July 25, 2025, with completion scheduled for July 28, 2025. The contract utilizes firm fixed price pricing with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a $20,941.94 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units). The contract was competitively awarded without set-aside designation and carries an ultimate completion date of August 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $3,128.96 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on July 18, 2025, with an ultimate completion date of July 21, 2025. This competitive award, issued without set-aside designation, represents a firm fixed-price delivery order for pharmaceutical supply fulfillment. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $10,781.30 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Jardiance 25 mg tablets (90-count packages). This firm fixed-price contract, with an ultimate completion date of July 25, 2025, represents a single delivery order under the company's broader pharmaceutical supply agreement. The award utilizes no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP6X2Delivery Order
The Defense Logistics Agency awarded a $3,063.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count) with an ultimate completion date of July 31, 2025. This non-set-aside competitive award was issued on July 30, 2025, to be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order represents a routine procurement under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables comprehensive pharmaceutical support globally, encompassing specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs. The company's successful track record fulfilling competitive federal procurement requirements across diverse medical product categories positions it to meet the Defense Health Agency and other government healthcare system needs through this flexible contracting mechanism.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/30/25 |